ADEQUATE IMMUNIZATION AND CREATION OF COLLECTIVE IMMUNITY FROM COVID-19 IN MODERN CONDITIONS
DOI:
https://doi.org/10.11603/1681-2727.2021.4.12839Keywords:
COVID-19, vaccination, legal framework, safety profileAbstract
The authors note the significant anti-epidemic failure of currently used coronavirus vaccines, despite the significant level of immunization of the population. Nevertheless, vaccination avoids severe or extremely severe COVID-19 and death from the disease.
The officially announced excess of tension and protective activity of post-vaccination anti-vaccine immunity compared to post-infection is discussed.
The problems of the legal basis of vaccination against COVID-19 in Ukraine are considered. It is proposed to include in this regulatory framework a new clinical standard (protocols, regulations, instructions), which oblige to determine before vaccination for each patient the feasibility of vaccination against COVID-19 and mandatory specificity of the safety profile of vaccination against COVID-19 and individual safety of the specific vaccine used.
The author’s algorithm for assessing the feasibility and safety of vaccination from COVID-19 is presented.
References
WHO Coronavirus (COVID-19) Dashboard. – https://covid19.who.int/08/11/2021
WHO Coronavirus (COVID-19) Global Ukraine. – https://covid19.who.int/region/euro/country/ua, 08/11/2021
WHO (08/11/21). Status of COVID-19. Vaccines within WHO EUL/PQ evaluation process. – https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_20Oct2021.pdf
Bondarenko, A. M., Kopcha, V. S. (2021). Practical assessment of the effectiveness, feasibility and safety of vaccines from COVID 19. Health of Ukraine. Thematic issue “Pulmonology, Allergology, Rhinolaryngology”, 1(54), 3-6. – https://health-ua.com/article/65448-praktichna-otcnka-efektivnost--dotclnost-tabezpechnost-zastosuvannya--vaktc [in Ukrainian].
Bondarenko, A. M. (2019). Vaccination – assessment of feasibility and risks. Infectious diseases – Infektsiyni khvoroby, 2, 77-95 [in Ukrainian].
CDC (2021). Vaccination provides more reliable protection than COVID-19. – https://www.cdc.gov/media/releases/2021/s1029-Vaccination-Offers-
Ministry of Health of the Russian Federation, Federal Service for Surveillance in Healthcare (Roszdravnadzor). (2021). About the international format for assessing the level of immunoglobulins, including IgG to SARS-CoV-2, 02i-840/21, 3 р. [in Russian].
Pfizer antiviral slashes COVID-19 hospitalization. Given early infection experimental pill prevents severe diseases, trial suggest. Science, 05/11/2021. – https://www.science.org/content/article/pfizer-antiviral-slashes-covid-19-hospitalizations 08/11/2021
Pfizer’s Covid-19 Oral Antiviral Treatment Paxlovid Reduces Risk of Hospitalization and Death. Drugs.com, Clinical Trials. – https://www.drugs.com/clinical_trials/pfizer-s-covid-19-oral-antiviral-paxlovid-Reduces-risk-hospitalization-death-19762.html 08/11/2021
Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced Risk of Hospitalization or Death Approximately 50% Compared to Placebo for Patients with Mild Interim Analysis of Phase 3 Study. Drugs.com, Clinical Trials. – https://www.drugs.com/clinical_trials/merck-ridgeback-s-investigational-oral-antiviral-molnupiravir-reduced-risk-hospitalization-death-19657.html 08.11.2021
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Infectious Diseases
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
